Stock Screener App

Frei -

Installieren

2.53

2.32% -0.06

Sab Biotherapeutics Inc (SABS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	16.90% 23.38	20.00	15.77	12.68	9.7321
Operating Income/Loss	16.90% -23.38	-20.00	-15.77	-12.68	-9.7321
Nonoperating Income/Loss	21.51% 0.886	1.1289	-1.0905	58.12	-0.3822
Net Income/Loss	19.20% -22.49	-18.87	-16.86	45.45	-10.11
Basic Average Shares	48.91% 79.75	53.56	9.5613	10.66	9.2945
Diluted Average Shares	48.91% 79.75	53.56	31.04	77.86	9.2945
Basic Earnings Per Share	20.00% -0.28	-0.35	-0.51	0.50	-1.09
Diluted Earnings Per Share	20.00% -0.28	-0.35	-0.46	-0.21	-1.09

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters